US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tevogen Bio Holdings

1.22

-0.0300-2.40%

Post-market: 1.220.00000.00%17:26 EDT

Volume:313.03K

Turnover:381.60K

Market Cap:225.02M

PE:-5.95

High:1.24

Open:1.23

Low:1.20

Close:1.25

Loading ...

Overview Company News Filings

Tevogen Bio Holdings Relocates to New Warren HQ, CEO Invests in Future Growth

Tevogen Bio Holdings Inc. Conducted Annual Stockholders Meeting

Tevogen files to sell 30.73M shares of common stock for holders

BRIEF-Tevogen Bio Holdings files for mixed shelf of up to $150 mln – SEC filing

Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital

Tevogen Updates on Development of Ebv-Specific T Cell Therapy With Support From AI-Powered Target Discovery

THOMSON REUTERS

Tevogen Bio Announces Development Progress of New EBV-Specific T Cell Therapy for Potential Clinical Trials

Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital

Tevogen Bio Holdings Inc. CEO Ryan H. Saadi Reports Disposal of Common Shares

Tevogen expands headquarters in Warren, New Jersey

Tevogen Bio to Relocate R&D Center Employees to Expanded Warren, NJ Headquarters by June 2025

Tevogen details AI initiative, Tevogen.AI, with Microsoft, Databricks pacts

Tevogen Details Its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy With Microsoft and Databricks Partnerships

THOMSON REUTERS

Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital

Tevogen announces planned expansion of TVGN 489’s target population

Tevogen Bio Expands Target Population to Include Seniors, Projects Nearly $1 Billion in First-Year Revenue

Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital

Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest

Biotech Alert: Searches spiking for these stocks today

Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TVGN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGN\",,,,,undefined,":{"symbol":"TVGN","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings","latestPrice":1.22,"timestamp":1751400000000,"preClose":1.25,"halted":0,"volume":313027,"hourTrading":{"tag":"盘后","latestPrice":1.22,"preClose":1.22,"latestTime":"17:26 EDT","volume":2910,"amount":3550.2,"timestamp":1751405165768},"delay":0,"floatShares":20868464,"shares":184443433,"eps":-0.204889,"marketStatus":"Post-Mkt","change":-0.03,"latestTime":"07-01 18:21:49 EDT","open":1.23,"high":1.24,"low":1.2,"amount":381600.4162685,"amplitude":0.032,"askPrice":1.23,"askSize":44,"bidPrice":1.21,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.204889,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1751414400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":1.25,"preHourTrading":{"tag":"盘前","latestPrice":1.2074,"preClose":1.25,"latestTime":"09:24 EDT","volume":14571,"amount":17604.1838718,"timestamp":1751376280017},"postHourTrading":{"tag":"盘后","latestPrice":1.22,"preClose":1.22,"latestTime":"17:26 EDT","volume":2910,"amount":3550.2,"timestamp":1751405165768},"volumeRatio":0.504822},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGN\",,,,,undefined,":{"symbol":"TVGN","floatShares":20868464,"roa":"-578.29%","roe":"--","lyrEps":-0.070045,"volumeRatio":0.504822,"shares":184443433,"dividePrice":0,"high":1.24,"amplitude":0.032,"preClose":1.25,"low":1.2,"week52Low":0.2556,"pbRate":"-13.62","week52High":3.09,"institutionHeld":0,"latestPrice":1.22,"committee":0.388889,"eps":-0.204889,"divideRate":0,"volume":313027,"delay":0,"ttmEps":-0.204889,"open":1.23,"prevYearClose":1.03,"prevWeekClose":1.24,"prevMonthClose":1.25,"prevQuarterClose":1.25,"fiveDayClose":1.18,"twentyDayClose":1.29,"sixtyDayClose":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVGN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548735014","title":"Tevogen Bio Holdings Relocates to New Warren HQ, CEO Invests in Future Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2548735014","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548735014?lang=en_us&edition=fundamental","pubTime":"2025-07-01 02:29","pubTimestamp":1751308140,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc. announced the relocation of its corporate headquarters to Warren, New Jersey, more than doubling its previous space. The move centralizes key teams, including research and regulatory affairs, and supports the Tevogen.AI initiative. CEO Ryan Saadi personally contributed $500,000 towards the facility's build-out and first-year operations, underscoring leadership's commitment to advancing accessible, affordable cell therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tevogen Bio Holdings Inc. published the original content used to generate this news brief via GlobeNewswire  on June 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL3znwkS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210150020.SGD","TVGN","IE00BGHQF748.EUR","BK4139","IE00BKPKM429.USD","BK4112","IE00B64PRP62.GBP","BK4588","IE00B3QW5Z07.USD","NDAQ","LU2210149790.SGD","BK4585"],"gpt_icon":0},{"id":"2545344077","title":"Tevogen Bio Holdings Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2545344077","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545344077?lang=en_us&edition=fundamental","pubTime":"2025-06-24 05:07","pubTimestamp":1750712841,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc. held its Annual Meeting of Stockholders on June 23, 2025. The stockholders elected Jeffrey Feike and Dr. Curtis Patton to the Board of Directors. Additionally, the appointment of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tevogen Bio Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 23, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nNDL1Pmn6m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"2545103953","title":"Tevogen files to sell 30.73M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2545103953","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545103953?lang=en_us&edition=fundamental","pubTime":"2025-06-21 05:35","pubTimestamp":1750455321,"startTime":"0","endTime":"0","summary":"17:30 EDT Tevogen (TVGN) files to sell 30.73M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, mar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-files-to-sell-30-73m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-files-to-sell-30-73m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"2545585103","title":"BRIEF-Tevogen Bio Holdings files for mixed shelf of up to $150 mln – SEC filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2545585103","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545585103?lang=en_us&edition=fundamental","pubTime":"2025-06-21 05:28","pubTimestamp":1750454886,"startTime":"0","endTime":"0","summary":"BRIEF-Tevogen Bio Holdings files for mixed shelf of up to $150 mln – SEC filingJune 20  - Tevogen Bio Holdings Inc TVGN.O:TEVOGEN BIO HOLDINGS INC FILES FOR MIXED SHELF OF UP TO $150 MILLION – SEC FILINGTEVOGEN BIO : PROSPECTUS ALSO COVERS OFFERING, POTENTIAL RESALE BY SELLING STOCKHOLDERS OF UP TO 30.7 MILLION SHARES FROM TIME TO TIMESource text: [ID:n0001641172-25-015914]Further company coverage: TVGN.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nFWN3SN0EJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2544970782","title":"Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2544970782","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544970782?lang=en_us&edition=fundamental","pubTime":"2025-06-18 21:23","pubTimestamp":1750252980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TVGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 18, 2025 09:23 ET (13:23 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN"],"gpt_icon":0},{"id":"2544727229","title":"Tevogen Updates on Development of Ebv-Specific T Cell Therapy With Support From AI-Powered Target Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2544727229","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544727229?lang=en_us&edition=fundamental","pubTime":"2025-06-18 20:31","pubTimestamp":1750249883,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nFWN3SL0CM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2544794972","title":"Tevogen Bio Announces Development Progress of New EBV-Specific T Cell Therapy for Potential Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2544794972","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544794972?lang=en_us&edition=fundamental","pubTime":"2025-06-18 20:30","pubTimestamp":1750249819,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc. has announced an update on the development of its EBV-specific T cell therapy, which targets Epstein-Barr virus-associated lymphomas. The company is in the process of selecting EBV peptides using computer-based methods as part of its preparation for a potential clinical trial. This trial will utilize EBV-specific CTLs manufactured with Tevogen's proprietary ExacTcell technology, known for its precision and scalability. The company's R&D laboratory has also commenced confirmation studies to validate CTL responses to the selected viral peptides. Tevogen Bio's scientific and clinical teams are collaborating with Tevogen.AI to advance peptide selection strategies, aiming to enhance therapeutic precision. The research is currently in the preclinical evaluation phase, and further updates will be provided as the study progresses. Results from this research have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative art","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL1BWwjB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2095319765.USD","IE00BGHQF748.EUR","BK4112","TVGN","LU2210150020.SGD","IE00BKPKM429.USD","BK4585","IE00B3QW5Z07.USD","BK4139","LU2210149790.SGD","NDAQ","BK4588"],"gpt_icon":0},{"id":"2542864319","title":"Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2542864319","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542864319?lang=en_us&edition=fundamental","pubTime":"2025-06-10 19:23","pubTimestamp":1749554580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TVGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 10, 2025 07:23 ET (11:23 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN"],"gpt_icon":0},{"id":"2542935550","title":"Tevogen Bio Holdings Inc. CEO Ryan H. Saadi Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2542935550","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542935550?lang=en_us&edition=fundamental","pubTime":"2025-06-10 07:14","pubTimestamp":1749510853,"startTime":"0","endTime":"0","summary":"Ryan H. Saadi, who is the Chief Executive Officer and a Director of Tevogen Bio Holdings Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tevogen Bio Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL8VGWgh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Tevogen Bio Holdings Inc. CEO Ryan H. Saadi Reports Disposal of Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"2542387284","title":"Tevogen expands headquarters in Warren, New Jersey","url":"https://stock-news.laohu8.com/highlight/detail?id=2542387284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542387284?lang=en_us&edition=fundamental","pubTime":"2025-06-09 21:15","pubTimestamp":1749474926,"startTime":"0","endTime":"0","summary":"Tevogen (TVGN) announced the execution of a lease agreement to expand its corporate headquarters in Warren, New Jersey, more than doubling its foot...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-expands-headquarters-in-warren-new-jersey-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-expands-headquarters-in-warren-new-jersey-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2540709347","title":"Tevogen Bio to Relocate R&D Center Employees to Expanded Warren, NJ Headquarters by June 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2540709347","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540709347?lang=en_us&edition=fundamental","pubTime":"2025-06-04 01:46","pubTimestamp":1748972808,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc. has announced plans to relocate employees from its Philadelphia research and development center to its expanded principal executive offices in Warren, New Jersey. This move follows the expiration of the current lease in Philadelphia in June 2025. The relocation comes after Tevogen Bio Inc., a subsidiary of Tevogen Bio Holdings, amended its lease to double the office space at the New Jersey location and extend the lease term until February 2033.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tevogen Bio Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL6trtdh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2539768672","title":"Tevogen details AI initiative, Tevogen.AI, with Microsoft, Databricks pacts","url":"https://stock-news.laohu8.com/highlight/detail?id=2539768672","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539768672?lang=en_us&edition=fundamental","pubTime":"2025-05-30 23:10","pubTimestamp":1748617825,"startTime":"0","endTime":"0","summary":"Tevogen (TVGN) provided stockholders a detailed overview of its artificial intelligence initiative, Tevogen.AI, aimed at integrating advanced machi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-details-ai-initiative-tevogen-ai-with-microsoft-databricks-pacts-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-details-ai-initiative-tevogen-ai-with-microsoft-databricks-pacts-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2404859667.USD","LU2028103732.USD","IE0034235188.USD","IE00B4JS1V06.HKD","LU0061474705.USD","LU1235295455.SGD","TVGN","LU2456880835.USD","LU2092937148.SGD","LU2452424414.USD","LU1043141396.HKD","IE00BHPRN162.USD","LU0689626769.HKD","IE00BWXC8680.SGD","IE00BYQQ9H92.USD","LU2097344357.USD","SGXZ81514606.USD","LU2191332357.HKD","BK4504","BK4503","IE00BLSP4239.USD","SG9999015341.SGD","LU2764262908.HKD","IE0004445239.USD","IE00B3SWFQ91.USD","LU1582987597.SGD","BK4097","LU2413666699.HKD","LU0323239441.USD","LU0097036916.USD","LU0820562030.AUD","GB00B4QBRK32.GBP","LU0011850046.USD","LU0124676726.USD","LU1066051811.HKD","IE0004091025.USD","LU0553294199.USD","LU1697837992.HKD","LU2108987350.USD","LU0198837287.USD","LU1815333072.USD","LU0788109477.HKD","BK4581","IE00BK4W5M84.HKD","LU1670711123.USD","LU0545039389.USD","LU0950375773.USD","LU0314104364.USD","IE000W1ABFV2.USD"],"gpt_icon":0},{"id":"2539754592","title":"Tevogen Details Its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy With Microsoft and Databricks Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2539754592","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539754592?lang=en_us&edition=fundamental","pubTime":"2025-05-30 23:01","pubTimestamp":1748617278,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nTUA7VJJTW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1043141396.HKD","LU2506952170.USD","LU2023250504.SGD","LU1064131342.USD","LU2506952097.USD","LU1046421795.USD","LU2092937221.SGD","SG9999002232.USD","LU2452424414.USD","IE000YTNTUN2.SGD","BK4543","BK4097","LU1069344957.HKD","LU2028103732.USD","BK4525","LU1989772923.USD","LU0157215616.USD","BK4538","IE00BYXW3230.USD","LU0894486033.HKD","LU0061474705.USD","LU1127390331.HKD","LU2403377893.USD","LU2089283258.USD","LU1261432733.SGD","BK4567","LU0347712357.USD","LU0162691827.USD","BK4612","TVGN","LU2083900584.USD","LU1366192091.USD","LU1803068623.USD","LU1623119135.USD","LU0708994859.HKD","LU2237438978.USD","LU2111349929.HKD","LU0950375773.USD","LU2063271972.USD","TVGNW","LU1720051017.SGD","LU1712237335.SGD","LU2125154935.USD","LU0345774391.USD","MSFT","IE00B19Z8W00.USD","LU0149725797.USD","IE00BFXG0V08.USD","LU1235295455.SGD","LU2097344357.USD"],"gpt_icon":0},{"id":"2538465698","title":"Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2538465698","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538465698?lang=en_us&edition=fundamental","pubTime":"2025-05-27 19:49","pubTimestamp":1748346540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TVGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 27, 2025 07:49 ET (11:49 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN"],"gpt_icon":0},{"id":"2537154194","title":"Tevogen announces planned expansion of TVGN 489’s target population","url":"https://stock-news.laohu8.com/highlight/detail?id=2537154194","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537154194?lang=en_us&edition=fundamental","pubTime":"2025-05-24 03:55","pubTimestamp":1748030120,"startTime":"0","endTime":"0","summary":"Tevogen (TVGN) announced a planned expansion of TVGN 489’s target population to include patients 65 and older. Tevogen Bio’s Chief Commercial Offic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-announces-planned-expansion-of-tvgn-489s-target-population-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-announces-planned-expansion-of-tvgn-489s-target-population-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2537415469","title":"Tevogen Bio Expands Target Population to Include Seniors, Projects Nearly $1 Billion in First-Year Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2537415469","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537415469?lang=en_us&edition=fundamental","pubTime":"2025-05-24 03:50","pubTimestamp":1748029809,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc., trading on Nasdaq under the ticker symbol TVGN, has announced plans to expand its specialty care pipeline to include patients aged 65 and older, building on a previous revenue forecast of nearly $1 billion in its launch year. The cumulative five-year revenue estimate for Tevogen's specialty pharmaceuticals is projected to range between $18 billion and $22 billion. This expansion is set to enhance the market potential of the company's offerings. An updated forecast and the risk-adjusted net present value  will be released to reflect the inclusion of the 65+ patient demographic. In response to the detection of the more contagious COVID variant NB.1.8.1 in the U.S., initially identified in China, Tevogen Bio is prioritizing the expansion of clinical manufacturing capacity to meet significant unmet medical needs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and time","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL3MKTsN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","NDAQ"],"gpt_icon":0},{"id":"2534396275","title":"Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2534396275","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534396275?lang=en_us&edition=fundamental","pubTime":"2025-05-12 21:33","pubTimestamp":1747056780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TVGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 12, 2025 09:33 ET (13:33 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN"],"gpt_icon":0},{"id":"2532871819","title":"Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2532871819","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532871819?lang=en_us&edition=fundamental","pubTime":"2025-05-03 03:45","pubTimestamp":1746215100,"startTime":"0","endTime":"0","summary":"WARREN, N.J., May 02, 2025  -- Tevogen   today announced that, following the Company’s recent press release highlighting the Direct Registration System  as a secure method of share ownership, it has received a number of inquiries from shareholders seeking additional information on how to transfer their shares to a DRS account.In response, Tevogen will provide step-by-step guidance early next week to help interested shareholders register their shares directly with the Company’s transfer agent, Continental Stock Transfer & Trust.The Company also notes that several of its largest shareholders, both internal and external, have elected to hold their shares via DRS, underscoring their confidence in this method of direct ownership.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tevogen-share-direct-registration-system-194500249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DRS","IE00B19Z4B17.USD","TVGN","TVGNW","IE00B66KJ199.SGD","IE00B7SZL793.SGD","BK4187","IE0031619046.USD"],"gpt_icon":0},{"id":"2532000582","title":"Biotech Alert: Searches spiking for these stocks today","url":"https://stock-news.laohu8.com/highlight/detail?id=2532000582","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532000582?lang=en_us&edition=fundamental","pubTime":"2025-05-02 00:15","pubTimestamp":1746116123,"startTime":"0","endTime":"0","summary":"These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:. Discover companies with rock-solid fundamentals in  TipRanks' Smart Value Newsletter.Receive undervalued stocks, resilient to market uncertainty,  delivered straight to your inbox.Tevogen Bio Holdings , 332% surge in interest. Pipeline and key clinical candidates for these companies:. Galmed is a clinical stage biopharmaceutical company focused on the development of Aramchol for liver and fibro-inflammatory diseases. The company has focused almost exclusively on developing Aramchol for the treatment of noncirrhotic nonalcoholic steatohepatitis, or NASH, and are currently developing Aramchol for Primary Sclerosing Cholangitis, or PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of liver disease.CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biotech-alert-searches-spiking-stocks-161523387.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-alert-searches-spiking-stocks-161523387.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0009355771.USD","IE00BJJMRZ35.SGD","BK4588","BCDA","IE00BJT1NW94.SGD","BCDAW","LU0320765489.SGD","CMMB","LU0211331839.USD","CGON","IE0002141913.USD","BK4578","BK4585","IE00B2B36J28.USD","SWTX","BK4532","TVGNW","BK4007","IE00B4R5TH58.HKD","LU0208291251.USD","TVGN","RGLS","SNTI","GLMD","NVS","BK4539","MKKGY","BK4139","IE00BFTCPJ56.SGD","LU0070302665.USD"],"gpt_icon":0},{"id":"2531726767","title":"Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts","url":"https://stock-news.laohu8.com/highlight/detail?id=2531726767","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531726767?lang=en_us&edition=fundamental","pubTime":"2025-04-30 01:48","pubTimestamp":1745948880,"startTime":"0","endTime":"0","summary":"WARREN, N.J., April 29, 2025  -- Tevogen  , today informed shareholders about several differences between holding shares in Direct Registration System  accounts and holding them in brokerage accounts.A DRS account is an alternative to using a brokerage account and Tevogen encourages shareholders to explore the differences. DRS accounts ensure your shares are registered directly in your name and not held through intermediary brokers, allowing shareholder to exercise direct control over their shares. DRS accounts may also have reduced transaction and account maintenance costs for shareholders. Brokerage accounts may provide greater access to tools, and selling shares in this type of account may be quicker when compared to a DRS account. Investors may also incur certain costs in connection with transferring shares in and out of a brokerage account.For more information about these and other differences, please contact the Company’s transfer agent, Continental Stock Transfer & Trust.Tevogen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tevogen-informs-public-shareholders-drs-174800183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z4B17.USD","IE0031619046.USD","BK4187","DRS","IE00B7SZL793.SGD","TVGN","TVGNW","IE00B66KJ199.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":73,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"TVGN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-02-15","symbol":"TVGN","reason":null,"defaultRemindTime":1708007400000,"announcedDate":"2024-02-14","type":"delisting","dateTimestamp":1707973200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1741924800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TVGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TVGN","date":"2025-06-30","current":-6.46817,"percent":0.827044,"low":-87.683882,"twenty":-31.599083,"median":-17.065337,"eighty":-6.708918,"high":-2.106753,"avg":-21.062331,"sd":15.91342,"marketCap":228709856},"quantilePoints":[{"date":"2024-03-01","current":-58.029616,"twenty":-57.969868,"median":-57.58151,"eighty":-55.109463,"marketCap":1279054027},{"date":"2024-03-08","current":-55.116932,"twenty":-57.969868,"median":-57.3948,"eighty":-55.049716,"marketCap":1214854404},{"date":"2024-03-15","current":-48.544723,"twenty":-57.715942,"median":-55.116932,"eighty":-49.664986,"marketCap":1069993717},{"date":"2024-03-22","current":-31.890149,"twenty":-57.596447,"median":-52.465643,"eighty":-44.108482,"marketCap":702903564},{"date":"2024-03-28","current":-25.919148,"twenty":-57.357457,"median":-49.38492,"eighty":-32.983824,"marketCap":571294337},{"date":"2024-04-05","current":-25.392625,"twenty":-55.998205,"median":-48.543977,"eighty":-28.607629,"marketCap":559689021},{"date":"2024-04-12","current":-18.446995,"twenty":-55.146806,"median":-35.064227,"eighty":-23.267262,"marketCap":406597612},{"date":"2024-04-19","current":-15.833048,"twenty":-54.915285,"median":-32.71989,"eighty":-19.118705,"marketCap":348982566},{"date":"2024-04-26","current":-6.348156,"twenty":-53.503754,"median":-29.329228,"eighty":-17.595595,"marketCap":139922255},{"date":"2024-05-03","current":-7.365355,"twenty":-52.428301,"median":-25.919148,"eighty":-15.026459,"marketCap":162342739},{"date":"2024-05-10","current":-2.698495,"twenty":-50.822591,"median":-23.061357,"eighty":-9.708944,"marketCap":163198734},{"date":"2024-05-17","current":-2.422494,"twenty":-49.291565,"median":-20.164731,"eighty":-7.316959,"marketCap":146506832},{"date":"2024-05-24","current":-2.231961,"twenty":-48.694091,"median":-18.372311,"eighty":-2.71254,"marketCap":134983822},{"date":"2024-05-31","current":-2.106753,"twenty":-48.544425,"median":-17.961548,"eighty":-2.656034,"marketCap":127411559},{"date":"2024-06-07","current":-8.033143,"twenty":-47.558444,"median":-17.550785,"eighty":-2.656034,"marketCap":148265257},{"date":"2024-06-14","current":-7.903098,"twenty":-44.108482,"median":-15.833048,"eighty":-2.68298,"marketCap":145865070},{"date":"2024-06-21","current":-6.795171,"twenty":-36.221832,"median":-12.47226,"eighty":-2.696046,"marketCap":125416385},{"date":"2024-06-28","current":-6.570165,"twenty":-35.295748,"median":-12.322891,"eighty":-2.697026,"marketCap":121263525},{"date":"2024-07-05","current":-6.173255,"twenty":-33.757254,"median":-8.033143,"eighty":-2.703177,"marketCap":113937879},{"date":"2024-07-12","current":-6.299258,"twenty":-33.071802,"median":-7.830197,"eighty":-2.721904,"marketCap":116263481},{"date":"2024-07-15","current":-6.435162,"twenty":-32.983824,"median":-7.830197,"eighty":-2.721904,"marketCap":118771808},{"date":"2024-08-02","current":-5.57114,"twenty":-32.895846,"median":-7.830197,"eighty":-2.721904,"marketCap":102824824},{"date":"2024-08-09","current":-5.526139,"twenty":-32.222045,"median":-7.468419,"eighty":-3.563104,"marketCap":101994252},{"date":"2024-08-16","current":-20.612899,"twenty":-30.545833,"median":-7.468046,"eighty":-4.127144,"marketCap":122353801},{"date":"2024-08-23","current":-17.275162,"twenty":-29.265149,"median":-7.830197,"eighty":-4.681198,"marketCap":102541700},{"date":"2024-08-30","current":-14.308285,"twenty":-28.407028,"median":-7.866648,"eighty":-5.281333,"marketCap":84930944},{"date":"2024-09-06","current":-12.936966,"twenty":-27.171154,"median":-9.617885,"eighty":-5.454137,"marketCap":76791088},{"date":"2024-09-13","current":-14.230663,"twenty":-25.708539,"median":-12.097501,"eighty":-5.499138,"marketCap":84470197},{"date":"2024-09-20","current":-12.649478,"twenty":-24.871927,"median":-12.454498,"eighty":-5.544139,"marketCap":75084620},{"date":"2024-09-27","current":-11.784139,"twenty":-23.267262,"median":-12.36199,"eighty":-5.658262,"marketCap":69948149},{"date":"2024-10-04","current":-8.756889,"twenty":-21.942215,"median":-12.240382,"eighty":-5.887588,"marketCap":51979034},{"date":"2024-10-11","current":-9.208245,"twenty":-21.329829,"median":-12.040003,"eighty":-6.069393,"marketCap":54658190},{"date":"2024-10-18","current":-39.673363,"twenty":-24.871927,"median":-12.127687,"eighty":-6.141394,"marketCap":235492672},{"date":"2024-10-25","current":-73.596963,"twenty":-29.393307,"median":-12.327491,"eighty":-6.173255,"marketCap":436855971},{"date":"2024-10-31","current":-70.722082,"twenty":-31.779361,"median":-12.436737,"eighty":-6.180635,"marketCap":419791285},{"date":"2024-11-08","current":-32.773648,"twenty":-33.757254,"median":-12.633666,"eighty":-6.224556,"marketCap":194537424},{"date":"2024-11-15","current":-42.548244,"twenty":-38.983392,"median":-12.936966,"eighty":-6.285578,"marketCap":252557358},{"date":"2024-11-22","current":-36.270609,"twenty":-39.155884,"median":-13.187081,"eighty":-6.299438,"marketCap":287084045},{"date":"2024-11-29","current":-28.972255,"twenty":-38.235922,"median":-13.602501,"eighty":-6.300158,"marketCap":229317133},{"date":"2024-12-06","current":-23.222036,"twenty":-37.373458,"median":-13.816575,"eighty":-6.348156,"marketCap":183803809},{"date":"2024-12-13","current":-22.337387,"twenty":-36.270609,"median":-14.269474,"eighty":-6.435162,"marketCap":176801759},{"date":"2024-12-20","current":-21.33331,"twenty":-36.221832,"median":-15.004006,"eighty":-6.508963,"marketCap":168854432},{"date":"2024-12-27","current":-23.222036,"twenty":-35.303209,"median":-15.833048,"eighty":-6.557925,"marketCap":183803809},{"date":"2025-01-03","current":-23.443198,"twenty":-34.373394,"median":-17.065337,"eighty":-6.580965,"marketCap":185554321},{"date":"2025-01-10","current":-28.52993,"twenty":-33.790638,"median":-17.550785,"eighty":-6.670967,"marketCap":225816108},{"date":"2025-01-17","current":-26.760632,"twenty":-33.439732,"median":-17.684618,"eighty":-6.873653,"marketCap":211812008},{"date":"2025-01-24","current":-30.52039,"twenty":-33.171426,"median":-18.032197,"eighty":-7.005548,"marketCap":241570720},{"date":"2025-01-31","current":-29.635741,"twenty":-33.528197,"median":-18.446995,"eighty":-7.075423,"marketCap":234568670},{"date":"2025-02-07","current":-31.405039,"twenty":-33.171426,"median":-19.295444,"eighty":-7.138439,"marketCap":248572770},{"date":"2025-02-14","current":-34.501311,"twenty":-33.892862,"median":-20.164731,"eighty":-7.192457,"marketCap":273079945},{"date":"2025-02-21","current":-34.280148,"twenty":-34.280148,"median":-20.612899,"eighty":-7.244366,"marketCap":271329432},{"date":"2025-02-28","current":-27.645281,"twenty":-34.280148,"median":-21.570546,"eighty":-7.365355,"marketCap":218814058},{"date":"2025-03-07","current":-24.327847,"twenty":-34.058986,"median":-22.031836,"eighty":-7.370735,"marketCap":192556371},{"date":"2025-03-14","current":-24.54901,"twenty":-33.906622,"median":-22.226806,"eighty":-7.443187,"marketCap":194306884},{"date":"2025-03-21","current":-25.875983,"twenty":-33.837824,"median":-22.558549,"eighty":-7.452187,"marketCap":204809958},{"date":"2025-03-28","current":-26.53947,"twenty":-33.616662,"median":-23.000874,"eighty":-7.454567,"marketCap":210061496},{"date":"2025-04-04","current":-13.396106,"twenty":-33.174337,"median":-23.222036,"eighty":-7.467672,"marketCap":183893433},{"date":"2025-04-11","current":-13.396106,"twenty":-33.15978,"median":-22.669131,"eighty":-7.468419,"marketCap":183893433},{"date":"2025-04-17","current":-13.664028,"twenty":-32.994496,"median":-22.447968,"eighty":-7.468419,"marketCap":187571301},{"date":"2025-04-25","current":-13.530067,"twenty":-32.809553,"median":-22.063146,"eighty":-7.757841,"marketCap":185732367},{"date":"2025-05-02","current":-13.10675,"twenty":-32.74034,"median":-21.917772,"eighty":-7.830197,"marketCap":179921334},{"date":"2025-05-09","current":-14.601755,"twenty":-32.722315,"median":-21.231576,"eighty":-7.830197,"marketCap":200443841},{"date":"2025-05-16","current":-5.980818,"twenty":-32.552659,"median":-20.228412,"eighty":-7.830197,"marketCap":211477447},{"date":"2025-05-23","current":-6.396875,"twenty":-32.510851,"median":-19.566511,"eighty":-7.465051,"marketCap":226188922},{"date":"2025-05-30","current":-6.968954,"twenty":-32.378153,"median":-18.686729,"eighty":-7.414206,"marketCap":246417200},{"date":"2025-06-06","current":-7.333003,"twenty":-32.156991,"median":-18.297627,"eighty":-7.218412,"marketCap":259289740},{"date":"2025-06-13","current":-6.604904,"twenty":-32.068526,"median":-17.743768,"eighty":-7.033891,"marketCap":233544659},{"date":"2025-06-20","current":-6.240854,"twenty":-31.997175,"median":-17.550785,"eighty":-6.875341,"marketCap":220672119},{"date":"2025-06-27","current":-6.155194,"twenty":-31.696105,"median":-17.17025,"eighty":-6.729721,"marketCap":217643250},{"date":"2025-06-30","current":-6.46817,"twenty":-31.599083,"median":-17.065337,"eighty":-6.708918,"marketCap":228709856}],"updateTime":1751383031338}}}